Article Listing - GSK files Fluarix BLA with US FDA

FRENCH HEALTH COST CONTROL DEAL

20 April 1992

A revamped agreement between the French government and the medical profession on health care cost control (Marketletter March 16) has...

THE NEW EC REGULATORY ENVIRONMENT

20 April 1992

The main problem with the current procedures for registering pharmaceutical products within the member states of the European Community has...

BULLETIN REViEWS EPOETIN

20 April 1992

Addressing the role of recombinant erythropoietin as a treatment for anemic patients with renal failure and other potentially responsive conditions,...

IMMUNIZATION FORM CONFUSION IN USA

20 April 1992

A series of immunization information forms may be a source of confusion for many Americans seeking vaccinations for their children,...

US BIOSCIENCE STOCK SALE CANCELLED

20 April 1992

Marion Merrell Dow, the US pharmaceutical company, has withdrawn its request for registration and sale of all the common stock...

PATENT EXTENSION SOUGHT BY UPJOHN

20 April 1992

US pharmaceutical firm Upjohn, which is seeking an extension of the patent term of its non-steroidal anti-inflammatory drug Ansaid (flurbiprofen),...

TEVA'S GENERIC BRONCHODILATOR

20 April 1992

Israel's Teva Pharmaceutical Industries' US subsidiary, the Lemmon Company, has received approval from the US Food and Drug Administration to...

POSSIBLE ARTHRITIS TREATMENT DISCOVERED

20 April 1992

Biochemists at the University of Toronto, Canada, have discovered an antioxidant compound, purpurogallin, which they say could prevent cell damage...

IMMUNOSTIMULANT ACTION FOR CEFTAZIDIME?

20 April 1992

Scientists at a research institute of the Azerbaijan Health Ministry in the former USSR reportedly have discovered an immunostimulant action...

APPOINTMENTS AT UK HEALTH MINISTRY

20 April 1992

Following the Conservative victory at the UK General Election, Virginia Bottomley has moved up from Health Minister to become...

Showing 94431-94440 of 95569 articles

Go to beginningPreviousNextGo to end